Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan
· Delayed Price · Currency is JPY 2,489.00
+11.50 (0.46%)
Mar 10, 2026, 10:05 AM JST
Ono Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,164,196 | 752,707 | 1,152,917 | 1,349,755 | 1,512,876 | 1,442,521 | Upgrade
|
| Market Cap Growth | 61.26% | -34.71% | -14.58% | -10.78% | 4.88% | 16.26% | Upgrade
|
| Enterprise Value | 1,105,869 | 741,730 | 1,065,259 | 1,255,982 | 1,465,094 | 1,366,726 | Upgrade
|
| Last Close Price | 2477.50 | 1565.30 | 2293.81 | 2506.47 | 2716.61 | 2510.52 | Upgrade
|
| PE Ratio | 18.67 | 15.04 | 9.01 | 11.97 | 18.79 | 19.13 | Upgrade
|
| Forward PE | 17.06 | 11.12 | 10.24 | 10.81 | 13.49 | 17.11 | Upgrade
|
| PS Ratio | 2.29 | 1.55 | 2.29 | 3.02 | 4.19 | 4.66 | Upgrade
|
| PB Ratio | 1.38 | 0.96 | 1.44 | 1.81 | 2.29 | 2.25 | Upgrade
|
| P/TBV Ratio | 2.60 | 1.75 | 1.57 | 2.01 | 2.56 | 2.55 | Upgrade
|
| P/FCF Ratio | 9.76 | 9.77 | 10.81 | 8.75 | 26.86 | 21.54 | Upgrade
|
| P/OCF Ratio | 9.27 | 9.13 | 10.42 | 8.46 | 24.47 | 19.50 | Upgrade
|
| PEG Ratio | 11.65 | 1.39 | 1.39 | 1.39 | 0.81 | 1.40 | Upgrade
|
| EV/Sales Ratio | 2.17 | 1.52 | 2.12 | 2.81 | 4.05 | 4.42 | Upgrade
|
| EV/EBITDA Ratio | 9.95 | 8.36 | 5.97 | 7.50 | 11.40 | 11.93 | Upgrade
|
| EV/EBIT Ratio | 14.89 | 12.00 | 6.65 | 8.37 | 13.22 | 13.84 | Upgrade
|
| EV/FCF Ratio | 9.27 | 9.63 | 9.99 | 8.14 | 26.01 | 20.41 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.12 | 1.65 | 0.05 | 0.05 | 0.07 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 1.04 | 1.90 | 0.08 | 0.06 | 0.16 | 0.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.08 | -0.08 | -0.20 | -0.12 | -0.09 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.58 | -0.70 | -0.88 | -0.52 | -0.47 | -0.48 | Upgrade
|
| Net Debt / FCF Ratio | -0.54 | -0.81 | -1.47 | -0.56 | -1.07 | -0.82 | Upgrade
|
| Asset Turnover | 0.47 | 0.49 | 0.56 | 0.55 | 0.49 | 0.44 | Upgrade
|
| Inventory Turnover | 2.14 | 2.40 | 2.72 | 2.54 | 2.31 | 2.38 | Upgrade
|
| Quick Ratio | 2.36 | 2.32 | 2.92 | 1.71 | 2.56 | 1.58 | Upgrade
|
| Current Ratio | 3.02 | 3.07 | 3.99 | 2.81 | 4.27 | 2.64 | Upgrade
|
| Return on Equity (ROE) | 7.50% | 6.32% | 16.56% | 16.02% | 12.39% | 12.49% | Upgrade
|
| Return on Assets (ROA) | 4.20% | 3.91% | 11.16% | 11.57% | 9.32% | 8.69% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.84% | 7.64% | 19.25% | 18.70% | 14.34% | 13.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.90% | 6.70% | 19.80% | 19.80% | 16.50% | 15.10% | Upgrade
|
| Earnings Yield | 5.36% | 6.65% | 11.10% | 8.35% | 5.32% | 5.23% | Upgrade
|
| FCF Yield | 10.24% | 10.23% | 9.25% | 11.43% | 3.72% | 4.64% | Upgrade
|
| Dividend Yield | 3.17% | 5.11% | 3.49% | 2.79% | 2.06% | 1.99% | Upgrade
|
| Payout Ratio | 59.97% | 74.96% | 29.05% | 26.38% | 34.36% | 29.76% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | 2.14% | 1.70% | 1.65% | 0.54% | 0.96% | Upgrade
|
| Total Shareholder Return | 3.15% | 7.25% | 5.19% | 4.44% | 2.60% | 2.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.